Work

TMAO, A Gut Microbiome Derived Metabolite, and its Contribution to the Development of Cardiovascular Disease (CVD)

Year: 2026

Type: article

Abstract: Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, with atherosclerosis as its primary driver. While traditional risk factors are well-understood, the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) is an emerging, critical determinant of cardiovascular health. This systematic review evaluates the mechanistic links between TMAO and atherosclerosis, drawing from animal and human studies, and assesses the efficacy of dietary, microbial, and pharmacological interventions. Elevated TMAO levels consistently correlate with platelet hyperreactivity, endothelial dysfunction, and vascular inflammation. Interventions like the Mediterranean diet, exercise, and enzyme inhibitors like berberine show significant potential in reducing TMAO levels and mitigating CVD risk.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.19582571

Authors: Bin Ishaq, Mussab, Chinthala, Trisha, Mukhi, Adil

Institutions: Can Tho University of Medicine and Pharmacy, University of Toronto

Language: English

Topic: Gut microbiota and health

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7154232967

FWCI:

Cites:

Cited by:

Related to: